StoryFunding
Structure Therapeutics completes IPO on NASDAQ under ticker GPCR, raising $167M
Structure Therapeutics went public on the NASDAQ under the ticker symbol GPCR, raising approximately $167M in net proceeds. The IPO valued the company to advance its clinical programs in oral small-molecule GPCR modulators.
- IPO raised $167 million in net proceeds to advance aleniglipron and other programs.
- Listed on NASDAQ under ticker GPCR.
- Valuation reflects investor confidence in oral GLP-1 pill approach.